Main competitors
1m. Revenue rev. 4m. EPS revision 4m. Revenue rev. 1y. EPS revision 1y. Revenue rev. Visibility Nbr of analysts
15
28
22
28
18
21
21
24
29
27
27
29
24
19
23
15
18
15
16
Average 22
Weighted average by Cap. 24
Other Pharmaceuticals